Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse () Free

Abstract

We used a deer mouse () infection model to test the protective efficacy of genetic vaccine candidates for Sin Nombre (SN) virus that were known to provoke immunological responses in BALB/c mice (Bharadwaj ., 17, 2836–2843, 1999). Protective epitopes were localized in each of four overlapping cDNA fragments that encoded portions of the SN virus G1 glycoprotein antigen; the nucleocapsid gene also was protective. The protective efficacy of glycoprotein gene fragments correlated with splenocyte proliferation in the presence of cognate antigen, but none induced neutralizing antibodies. Genetic vaccines against SN virus can protect outbred deer mice from infection even in the absence of a neutralizing antibody response.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-7-1745
2002-07-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/7/0831745a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-7-1745&mimeType=html&fmt=ahah

References

  1. Arikawa J., Lapenotiere H. F., Iacono-Connors L., Wang M. L., Schmaljohn C. S. 1990; Coding properties of the S and the M genome segments of Sapporo rat virus: comparison to other causative agents of hemorrhagic fever with renal syndrome. Virology 176:114–125
    [Google Scholar]
  2. Bharadwaj M., Botten J., Torrez-Martinez N., Hjelle B. 1997; Rio Mamore virus: genetic characterization of a newly recognized hantavirus of the pygmy rice rat, Oligoryzomys microtis , from Bolivia. American Journal of Tropical Medicine and Hygiene 57:368–374
    [Google Scholar]
  3. Bharadwaj M., Lyons C. R., Wortman I. A., Hjelle B. 1999; Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine 17:2836–2843
    [Google Scholar]
  4. Bharadwaj M., Nofchissey R., Goade D., Koster F., Hjelle B. 2000; Humoral immune responses in the hantavirus cardiopulmonary syndrome. Journal of Infectious Diseases 182:43–48
    [Google Scholar]
  5. Botten J., Mirowsky K., Kusewitt D., Bharadwaj M., Yee J., Ricci R., Feddersen R. M., Hjelle B. 2000a; Experimental infection model for Sin Nombre hantavirus in the deer mouse ( Peromyscus maniculatus ). Proceedings of the National Academy of Sciences, USA 97:10578–10583
    [Google Scholar]
  6. Botten J., Nofchissey R., Ahern H., Rodriguez-Moran P., Wortman I. A., Goade D., Yates T., Hjelle B. 2000b; Outdoor facility for quarantine of wild rodents infected with hantavirus. Journal of Mammalogy 81:250–259
    [Google Scholar]
  7. Botten J., Ricci R., Hjelle B. 2001; Establishment of a deer mouse ( Peromyscus maniculatus rufinus ) breeding colony from wild-caught founders. Comparative Medicine 51:291–295
    [Google Scholar]
  8. Bradford M. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
    [Google Scholar]
  9. Centers for Disease Control & Prevention 1994; Laboratory management of agents associated with hantavirus pulmonary syndrome: interim biosafety guidelines. Morbidity and Mortality Weekly Report 43:1–7
    [Google Scholar]
  10. Childs J. E., Ksiazek T. G., Spiropoulou C. F., Krebs J. W., Morzunov S., Maupin G. O., Gage K. L., Rollin P. E., Sarisky J., Enscore R. E. 1994; Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. Journal of Infectious Diseases 169:1271–1280
    [Google Scholar]
  11. Cho H. W., Howard C. R. 1999; Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax). Vaccine 17:2569–2575
    [Google Scholar]
  12. Chu Y. K., Jennings G. B., Schmaljohn C. S. 1995; A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus. Journal of Virology 69:6417–6423
    [Google Scholar]
  13. Ebihara H., Yoshimatsu K., Ogino M., Araki K., Ami Y., Kariwa H., Takashima I., Li D., Arikawa J. 2000; Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence. Journal of Virology 74:9245–9255
    [Google Scholar]
  14. Enria D., Padula P., Segura E. L., Pini N., Edelstein A., Posse C. R., Weissenbacher M. C. 1996; Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina (Buenos Aires) 56:709–711
    [Google Scholar]
  15. Hjelle B., Chavez-Giles F., Torrez-Martinez N., Yamada T., Sarisky J., Ascher M., Jenison S. 1994; Dominant glycoprotein epitope of Four Corners hantavirus is conserved across a wide geographical area. Journal of General Virology 75:2881–2888
    [Google Scholar]
  16. Hooper J. W., Kamrud K. I., Elgh F., Custer D., Schmaljohn C. S. 1999; DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection. Virology 255:269–278
    [Google Scholar]
  17. Hooper J. W., Larsen T., Custer D. M., Schmaljohn C. S. 2001; A lethal disease model for hantavirus pulmonary syndrome. Virology 289:6–14
    [Google Scholar]
  18. Khan A. S., Ksiazek T. G., Peters C. J. 1996; Hantavirus pulmonary syndrome. Lancet 347:739–741
    [Google Scholar]
  19. Lee H. W., van der Groen G. 1989; Hemorrhagic fever with renal syndrome. Progress in Medical Virology 36:62–102
    [Google Scholar]
  20. Lober C., Anheier B., Lindow S., Klenk H. D., Feldmann H. 2001; The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology 289:224–229
    [Google Scholar]
  21. Lundkvist A., Kallio-Kokko H., Sjolander K. B., Lankinen H., Niklasson B., Vaheri A., Vapalahti O. 1996; Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity. Virology 216:397–406
    [Google Scholar]
  22. McClain D. J., Summers P. L., Harrison S. A., Schmaljohn A. L., Schmaljohn C. S. 2000; Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. Journal of Medical Virology 60:77–85
    [Google Scholar]
  23. Mills J. N., Yates T. L., Childs J. E., Parmenter R. R., Ksiazek T. G., Rollin P. E., Peters C. J. 1995; Guidelines for working with rodents potentially infected with hantavirus. Journal of Mammalogy 76:716–722
    [Google Scholar]
  24. Nichol S. T., Spiropoulou C. F., Morzunov S., Rollin P. E., Ksiazek T. G., Feldmann H., Sanchez A., Childs J., Zaki S., Peters C. J. 1993; Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness [see comments]. Science 262:914–917
    [Google Scholar]
  25. Plyusnin A., Vapalahti O., Vaheri A. 1996; Hantaviruses: genome structure, expression and evolution. Journal of General Virology 77:2677–2687
    [Google Scholar]
  26. Schmaljohn C. S. 1996; Bunyaviridae : the viruses and their replication. In Fields Virology pp 1447–1471 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  27. Schmaljohn C., Hjelle B. 1997; Hantaviruses: a global disease problem. Emerging Infectious Diseases 3:95–104
    [Google Scholar]
  28. Schmaljohn C. S., Hasty S. E., Dalrymple J. M., Leduc J. W., Lee H. W., von Bonsdorff C. H., Brummer-Korvenkontio M., Vaheri A., Tsai T. F., Regnery H. L. 1985; Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 227:1041–1044
    [Google Scholar]
  29. Schmaljohn C. S., Schmaljohn A. L., Dalrymple J. M. 1987; Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order. Virology 157:31–39
    [Google Scholar]
  30. Schmaljohn C. S., Chu Y. K., Schmaljohn A. L., Dalrymple J. M. 1990; Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. Journal of Virology 64:3162–3170
    [Google Scholar]
  31. Schmaljohn C. S., Hasty S. E., Dalrymple J. M. 1992; Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine 10:10–13
    [Google Scholar]
  32. Tsai T. F., Bauer S., McCormick J. B., Kurata T. 1982; Intracerebral inoculation of suckling mice with Hantaan virus [letter]. Lancet 2:503–504
    [Google Scholar]
  33. Ulrich R., Lundkvist A., Meisel H., Koletzki D., Sjolander K. B., Gelderblom H. R., Borisova G., Schnitzler P., Darai G., Kruger D. H. 1998; Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine 16:272–280
    [Google Scholar]
  34. Wang M. W., Pennock D. G., Spik K. W., Schmaljohn C. S. 1992; Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus. Virology 192:757–766
    [Google Scholar]
  35. Yamada T., Hjelle B., Lanzi R., Morris C., Anderson B., Jenison S. 1995; Antibody responses to Four Corners hantavirus infections in the deer mouse ( Peromyscus maniculatus ): identification of an immunodominant region of the viral nucleocapsid protein. Journal of Virology 69:1939–1943
    [Google Scholar]
  36. Yoshimatsu K., Yoo Y. C., Yoshida R., Ishihara C., Azuma I., Arikawa J. 1993; Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Archives of Virology 130:365–376
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-7-1745
Loading
/content/journal/jgv/10.1099/0022-1317-83-7-1745
Loading

Data & Media loading...

Most cited Most Cited RSS feed